703 related articles for article (PubMed ID: 16860764)
21. Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection.
Hor JL; Whitney PG; Zaid A; Brooks AG; Heath WR; Mueller SN
Immunity; 2015 Sep; 43(3):554-65. PubMed ID: 26297566
[TBL] [Abstract][Full Text] [Related]
22. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
[TBL] [Abstract][Full Text] [Related]
23. DC infection promotes antiviral CTL priming: the 'Winkelried' strategy.
Freigang S; Probst HC; van den Broek M
Trends Immunol; 2005 Jan; 26(1):13-8. PubMed ID: 15629404
[TBL] [Abstract][Full Text] [Related]
24. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
25. Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells.
Belz GT; Bedoui S; Kupresanin F; Carbone FR; Heath WR
Nat Immunol; 2007 Oct; 8(10):1060-6. PubMed ID: 17767161
[TBL] [Abstract][Full Text] [Related]
26. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
Koide T; Iinuma H; Fukushima R
Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
[TBL] [Abstract][Full Text] [Related]
27. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
28. Antigen presentation by dendritic cells in vivo.
Segura E; Villadangos JA
Curr Opin Immunol; 2009 Feb; 21(1):105-10. PubMed ID: 19342210
[TBL] [Abstract][Full Text] [Related]
29. In vivo induction of immune responses to pathogens by conventional dendritic cells.
López-Bravo M; Ardavín C
Immunity; 2008 Sep; 29(3):343-51. PubMed ID: 18799142
[TBL] [Abstract][Full Text] [Related]
30. No significant CTL cross-priming by dendritic cell-derived exosomes during murine lymphocytic choriomeningitis virus infection.
Coppieters K; Barral AM; Juedes A; Wolfe T; Rodrigo E; Théry C; Amigorena S; von Herrath MG
J Immunol; 2009 Feb; 182(4):2213-20. PubMed ID: 19201875
[TBL] [Abstract][Full Text] [Related]
31. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.
Le Borgne M; Etchart N; Goubier A; Lira SA; Sirard JC; van Rooijen N; Caux C; Aït-Yahia S; Vicari A; Kaiserlian D; Dubois B
Immunity; 2006 Feb; 24(2):191-201. PubMed ID: 16473831
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
[TBL] [Abstract][Full Text] [Related]
34. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
Buonocore S; Haddou NO; Moore F; Florquin S; Paulart F; Heirman C; Thielemans K; Goldman M; Flamand V
J Leukoc Biol; 2008 Sep; 84(3):713-20. PubMed ID: 18567840
[TBL] [Abstract][Full Text] [Related]
36. CTL induction by cross-priming is restricted to immunodominant epitopes.
Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
[TBL] [Abstract][Full Text] [Related]
37. Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo.
Fernandez MA; Evans IA; Hassan EH; Carbone FR; Jones CA
Eur J Immunol; 2008 Jan; 38(1):102-13. PubMed ID: 18081035
[TBL] [Abstract][Full Text] [Related]
38. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.
Yang J; Huck SP; McHugh RS; Hermans IF; Ronchese F
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):147-52. PubMed ID: 16373503
[TBL] [Abstract][Full Text] [Related]
39. Presentation of self-antigens on MHC class II molecules during dendritic cell maturation.
Zwickey HL; Unternaehrer JJ; Mellman I
Int Immunol; 2006 Jan; 18(1):199-209. PubMed ID: 16361313
[TBL] [Abstract][Full Text] [Related]
40. Antigen-presentation properties of plasmacytoid dendritic cells.
Villadangos JA; Young L
Immunity; 2008 Sep; 29(3):352-61. PubMed ID: 18799143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
